enVVeno Medical Corporation (NVNO)
NASDAQ: NVNO · Real-Time Price · USD
11.46
-0.65 (-5.35%)
At close: Mar 6, 2026, 4:00 PM EST
11.46
0.00 (-0.02%)
After-hours: Mar 6, 2026, 4:10 PM EST
enVVeno Medical Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Selling, General & Admin | 11.7 | 11.58 | 11.66 | 15.02 | 11.17 | 4.88 | |
| Research & Development | 11.55 | 12.25 | 13.58 | 9.91 | 5.73 | 4.25 | |
| Operating Expenses | 23.25 | 23.83 | 25.24 | 24.93 | 16.89 | 9.14 | |
| Operating Income | -23.25 | -23.83 | -25.24 | -24.93 | -16.89 | -9.14 | |
| Interest & Investment Income | 0.75 | 0.39 | 0.18 | 0.16 | 0.02 | 0 | |
| Other Non Operating Income (Expenses) | - | - | - | - | 0.03 | -0 | |
| EBT Excluding Unusual Items | -22.5 | -23.44 | -25.06 | -24.77 | -16.84 | -9.14 | |
| Gain (Loss) on Sale of Investments | 0.87 | 1.62 | 1.54 | 0.1 | - | - | |
| Other Unusual Items | -0.34 | - | - | - | 0.31 | - | |
| Pretax Income | -21.97 | -21.82 | -23.52 | -24.67 | -16.53 | -9.14 | |
| Earnings From Continuing Operations | -21.97 | -21.82 | -23.52 | -24.67 | -16.53 | -9.14 | |
| Net Income | -21.97 | -21.82 | -23.52 | -24.67 | -16.53 | -9.14 | |
| Preferred Dividends & Other Adjustments | - | - | - | - | - | 0.61 | |
| Net Income to Common | -21.97 | -21.82 | -23.52 | -24.67 | -16.53 | -9.74 | |
| Shares Outstanding (Basic) | 1 | 0 | 0 | 0 | 0 | 0 | |
| Shares Outstanding (Diluted) | 1 | 0 | 0 | 0 | 0 | 0 | |
| Shares Change (YoY) | 27.53% | 39.35% | 29.87% | 9.12% | 572.11% | 104.86% | |
| EPS (Basic) | -37.85 | -44.55 | -66.91 | -91.15 | -66.65 | -264.04 | |
| EPS (Diluted) | -37.85 | -44.55 | -66.91 | -91.15 | -66.65 | -264.04 | |
| Free Cash Flow | -17.24 | -16.88 | -18.89 | -15.73 | -12.22 | -7.86 | |
| Free Cash Flow Per Share | -29.71 | -34.45 | -53.75 | -58.14 | -49.26 | -212.95 | |
| EBITDA | -23.11 | -23.64 | -25.02 | -24.72 | -16.74 | -9.04 | |
| D&A For EBITDA | 0.15 | 0.19 | 0.22 | 0.21 | 0.15 | 0.1 | |
| EBIT | -23.25 | -23.83 | -25.24 | -24.93 | -16.89 | -9.14 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.